| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.39 | 7e-13 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.35 | 5e-10 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.35 | 4e-09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.32 | 4e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.33 | 4e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |